Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fast Track designation
Biotech
J&J targets rare maternal-fetal disease: 'We're going for this'
More than 60 years after RhoGAM’s approval, J&J is hoping to build off its own legacy and bring another maternal fetal immunology treatment to market.
Gabrielle Masson
Apr 2, 2024 11:23am
Kyverna accelerates into another FDA fast track
Jan 19, 2024 10:26am
Chasing Pfizer, Regenxbio benefits from FDA boost in DMD
Apr 11, 2023 9:45am
Ayala and Advaxis fuse together to pool funds for lead programs
Oct 19, 2022 11:00am
FDA grants Silence's drug fast-track tag for a blood cancer
Sep 8, 2022 9:10am
Racing Bayer, Merck gets FDA fast-track tag for anticoagulant
Aug 23, 2022 8:40am
